Evidence map›Paper›PMID 30825655›Full record

ArticleBiochimica et biophysica acta. Gene regulatory mechanisms2019

The bZIP mutant CEBPB (V285A) has sequence specific DNA binding propensities similar to CREB1.

Sreejana Ray, Aniekanabasi Ufot, Nima Assad, Jocelyn Singh, Stewart R Durell, Aleksey Porollo, Desiree Tillo, Charles Vinson

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Gene regulatory mechanisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sreejana RayLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America.
Aniekanabasi UfotLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America.
Nima AssadLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America.
Jocelyn SinghLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America.
Stewart R DurellLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America.
Aleksey PorolloCenter for Autoimmune Genomics and Etiology, Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States of America; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, United States of America.
Desiree TilloLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America.
Charles VinsonLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States of America. Electronic address: vinsonc@mail.nih.gov.
National Institutes of Health · USCincinnati Children's Hospital Medical Center · US

Funding

Gene Regulation and Function: The B-ZIP ProteinsZIABC005271 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI VINSON, CHARLES · 2009 to 2019
$11.2M
Effects of Cytosine Modifications on Transcription Factor BindingZICBC011724 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DURELL, STEWART · 2016 to 2023
$961k
Intramural NIH HHS ZIA BC005271Intramural NIH HHS ZIC BC011724
6 · The paper itself

Abstract

The bZIP homodimers CEBPB and CREB1 bind DNA containing methylated cytosines differently. CREB1 binds stronger to the C/EBP half-site GCAA when the cytosine is methylated. For CEBPB, methylation of the same cytosine does not affect DNA binding. The X-ray structure of CREB1 binding the half site GTCA identifies an alanine in the DNA binding region interacting with the methyl group of T, structurally analogous to the methyl group of methylated C. This alanine is replaced with a valine in CEBPB. To explore the contribution of this amino acid to binding with methylated cytosine of the GCAA half-site, we made the reciprocal mutants CEBPB(V285A) and CREB1(A297V) and used protein binding microarrays (PBM) to examine binding to four types of double-stranded DNA (dsDNA): 1) DNA with cytosine in both strands (DNA(C|C)), 2) DNA with 5-methylcytosine (M) in one strand and cytosine in the second strand (DNA(M|C)), 3) DNA with 5-hydroxymethylcytosine (H) in one strand and cytosine in the second strand (DNA(H|C)), and 4) DNA with both cytosines in all CG dinucleotides containing 5-methylcytosine (DNA(5mCG)). When binding to DNA(C|C), CEBPB (V285A) preferentially binds the CRE consensus motif (TGACGTCA), similar to CREB1. The reciprocal mutant, CREB1(A297V) binds DNA with some similarity to CEBPB, with strongest binding to the methylated PAR site 8-mer TTACGTAA. These data demonstrate that V285 residue inhibits CEBPB binding to methylated cytosine of the GCAA half-site.

Indexed as

DNA MethylationBase SequenceCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCyclic AMP Response Element-Binding ProteinCytosineDNAMutationNucleotide MotifsPolymorphism, Single NucleotideProtein Array AnalysisProtein BindingCCAAT-Enhancer-Binding Protein-betaCCAAT-Enhancer-Binding ProteinsCyclic AMP Response Element-Binding ProteinCytosineDNA

Identifiers

PMID30825655
PMCPMC8127354
OpenAlexW2915332788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.